cognitive cybersecurity intelligence

News and Analysis

Search

Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting | News

As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at one-year follow-upAdditional data demonstrated…

Source: www.bakersfield.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

How Can NHIs Enhance Overall System Security?

How Can NHIs Enhance Overall System Security?

Non-Human Identity (NHI) management can offer essential protection for a business’s systems and data from potential cybersecurity threats, providing valuable benefits such as risk reduction,